4.6 Letter

17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use

Journal

ALLERGY
Volume 73, Issue 10, Pages 2083-2088

Publisher

WILEY
DOI: 10.1111/all.13499

Keywords

-

Funding

  1. Spanish Ministry of Economy and Competitiveness [RYC-2015-17205]
  2. Instituto de Salud Carlos III (ISCIII) [AC15/00015]
  3. ERACoSysMed 1st Joint Transnational Call (SysPharmPedia)
  4. European Social Funds from the European Union (ESF) ESF invests in your future
  5. U.S. National Institutes of Health
  6. Stichting Astma bestrijding
  7. Utrecht Institute for Pharmaceutical Sciences
  8. GSK
  9. MRC [MR/L006758/1] Funding Source: UKRI

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available